- Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutEli Lilly made a push in blood cancer at this year’s European Hematology Association meeting in Stockholm over the weekend. The drugmaker presented data for Jaypirca combined with the standard of…Endpoints · 1mo ago↗ source
- Celiac disease is entering a new era of therapeutic innovation<p>For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.</p>BioPharma Dive · 1mo ago↗ source
- Planning a successful pivot from lab to clinic<p>For sterile injectables, key early decisions can have a significant impact on the products’ development.</p>BioPharma Dive · 1mo ago